Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3987849010 | Ripretinib only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3987850010 | Product containing only ripretinib in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ripretinib only product in oral dose form | Is a | Product containing only ripretinib (medicinal product) | true | Inferred relationship | Some | ||
| Ripretinib only product in oral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Ripretinib only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Ripretinib only product in oral dose form | Is a | Ripretinib-containing product in oral dose form | true | Inferred relationship | Some | ||
| Ripretinib only product in oral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Ripretinib only product in oral dose form | Has active ingredient | Ripretinib (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ripretinib 50 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Ripretinib only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR